250 related articles for article (PubMed ID: 32445924)
1. Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution.
Vankadari N
Gene; 2020 Aug; 752():144792. PubMed ID: 32445924
[TBL] [Abstract][Full Text] [Related]
2. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.
Pachetti M; Marini B; Benedetti F; Giudici F; Mauro E; Storici P; Masciovecchio C; Angeletti S; Ciccozzi M; Gallo RC; Zella D; Ippodrino R
J Transl Med; 2020 Apr; 18(1):179. PubMed ID: 32321524
[TBL] [Abstract][Full Text] [Related]
3. Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity.
Jones LR; Manrique JM
Virology; 2020 Nov; 550():70-77. PubMed ID: 32890979
[TBL] [Abstract][Full Text] [Related]
4. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
[TBL] [Abstract][Full Text] [Related]
5. Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review.
Salajegheh Tazerji S; Magalhães Duarte P; Rahimi P; Shahabinejad F; Dhakal S; Singh Malik Y; Shehata AA; Lama J; Klein J; Safdar M; Rahman MT; Filipiak KJ; RodrÃguez-Morales AJ; Sobur MA; Kabir F; Vazir B; Mboera L; Caporale M; Islam MS; Amuasi JH; Gharieb R; Roncada P; Musaad S; Tilocca B; Koohi MK; Taghipour A; Sait A; Subbaram K; Jahandideh A; Mortazavi P; Abedini MA; Hokey DA; Hogan U; Shaheen MNF; Elaswad A; Elhaig MM; Fawzy M
J Transl Med; 2020 Sep; 18(1):358. PubMed ID: 32957995
[TBL] [Abstract][Full Text] [Related]
6. Host Immune Response Driving SARS-CoV-2 Evolution.
Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
[TBL] [Abstract][Full Text] [Related]
7. How did we get here? Short history of COVID-19 and other coronavirus-related epidemics.
Lango MN
Head Neck; 2020 Jul; 42(7):1535-1538. PubMed ID: 32445249
[TBL] [Abstract][Full Text] [Related]
8. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
[TBL] [Abstract][Full Text] [Related]
9. Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?
Eaaswarkhanth M; Al Madhoun A; Al-Mulla F
Int J Infect Dis; 2020 Jul; 96():459-460. PubMed ID: 32464271
[TBL] [Abstract][Full Text] [Related]
10. Full-genome sequences of the first two SARS-CoV-2 viruses from India.
Yadav PD; Potdar VA; Choudhary ML; Nyayanit DA; Agrawal M; Jadhav SM; Majumdar TD; Shete-Aich A; Basu A; Abraham P; Cherian SS
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):200-209. PubMed ID: 32242873
[TBL] [Abstract][Full Text] [Related]
11. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
Lvov DK; Alkhovsky SV
Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
[TBL] [Abstract][Full Text] [Related]
12. A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity.
Saha P; Banerjee AK; Tripathi PP; Srivastava AK; Ray U
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32378705
[TBL] [Abstract][Full Text] [Related]
13. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
Benedetti F; Snyder GA; Giovanetti M; Angeletti S; Gallo RC; Ciccozzi M; Zella D
J Transl Med; 2020 Aug; 18(1):329. PubMed ID: 32867854
[TBL] [Abstract][Full Text] [Related]
14. The viral, epidemiologic, clinical characteristics and potential therapy options for COVID-19: a review.
Li C; Xu BH
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4576-4584. PubMed ID: 32373998
[TBL] [Abstract][Full Text] [Related]
15. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
16. Characterization of codon usage pattern in SARS-CoV-2.
Hou W
Virol J; 2020 Sep; 17(1):138. PubMed ID: 32928234
[TBL] [Abstract][Full Text] [Related]
17. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
18. Multiple early introductions of SARS-CoV-2 into a global travel hub in the Middle East.
Tayoun AA; Loney T; Khansaheb H; Ramaswamy S; Harilal D; Deesi ZO; Varghese RM; Al Suwaidi H; Alkhajeh A; AlDabal LM; Uddin M; Hamoudi R; Halwani R; Senok A; Hamid Q; Nowotny N; Alsheikh-Ali A
Sci Rep; 2020 Oct; 10(1):17720. PubMed ID: 33082405
[TBL] [Abstract][Full Text] [Related]
19. Exploring the structural distribution of genetic variation in SARS-CoV-2 with the COVID-3D online resource.
Portelli S; Olshansky M; Rodrigues CHM; D'Souza EN; Myung Y; Silk M; Alavi A; Pires DEV; Ascher DB
Nat Genet; 2020 Oct; 52(10):999-1001. PubMed ID: 32908256
[No Abstract] [Full Text] [Related]
20. Corona virus versus existence of human on the earth: A computational and biophysical approach.
Zehra Z; Luthra M; Siddiqui SM; Shamsi A; Gaur NA; Islam A
Int J Biol Macromol; 2020 Oct; 161():271-281. PubMed ID: 32512089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
